Cargando…
Effect of Visit‐to‐Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the I (f) Inhibitor Ivabradine Trial (SHIFT) Trial
BACKGROUND: Elevated resting heart rate (HR) and low systolic blood pressure (SBP) are related to poor outcomes in heart failure (HF). The association between visit‐to‐visit variation in SBP and HR and risk in HF is unknown. METHODS AND RESULTS: In Systolic Heart Failure Treatment with the I (f) inh...
Autores principales: | Böhm, Michael, Robertson, Michele, Borer, Jeffrey, Ford, Ian, Komajda, Michel, Mahfoud, Felix, Ewen, Sebastian, Swedberg, Karl, Tavazzi, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802472/ https://www.ncbi.nlm.nih.gov/pubmed/26873681 http://dx.doi.org/10.1161/JAHA.115.002160 |
Ejemplares similares
-
Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study
por: Borer, Jeffrey S., et al.
Publicado: (2012) -
Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States
por: Borer, Jeffrey S., et al.
Publicado: (2016) -
Efficacy of ivabradine in heart failure patients with a high‐risk profile (analysis from the SHIFT trial)
por: Abdin, Amr, et al.
Publicado: (2023) -
Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.
por: Bouabdallaoui, Nadia, et al.
Publicado: (2019) -
Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy
por: Tardif, Jean-Claude, et al.
Publicado: (2011)